Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern baldness worsens with age and can be treated with medications like minoxidil and finasteride, but side effects and personalized care are important.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

More research is needed on alopecia areata treatments and its psychological effects.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

308 nm excimer phototherapy can help some people with alopecia areata regrow hair, especially if their condition is less severe.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Allergies and atopic conditions may increase the risk of developing alopecia areata.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Alopecia areata is increasing globally, with disparities needing better prevention and support.

Significant, lasting hair regrowth is needed to improve how patients with Alopecia Areata feel about their condition.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Alopecia areata is more common in young Black African males, with rare other health issues.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Mice with autoimmune hair loss showed signs of heart problems.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.